| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 0.0005 |